BQ 3020 [1468]



BQ 3020


SMILES CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(C)=O)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)C(C)C
InChIKey KBQLINQFUQUHIY-SGOWJZKMSA-N
Sequence LMDKEAVYFAHLDIIW
HELM PEPTIDE1{[ac].L.M.D.K.E.A.V.Y.F.A.H.L.D.I.V.W}$$$$

Chemical Properties

Hydrogen bond acceptors 24
Hydrogen bond donors 24
Rotatable bonds 62
Log P -0.085
Molecular weight (Da) 1991.0
Stereochemistry info partial

Database connections

Structure pdb 8XVE


Bioactivities

Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database
Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database

BQ 3020


Drug properties

Molecular type Peptide
Physiological/Surrogate Surrogate
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections

Structure pdb 8XVE


Compound is not listed as a drug.